Mitochondrial DNA-dependent effects of valproate on mitochondrial calcium levels in transmitochondrial cybrids

International Journal of Neuropsychopharmacology

Volumn 11, Issue 1, 2008, Pages 71-78

  Kazuno, An A ^a,b   Munakata, Kae ^a   Kato, Nobumasa ^b   Kato, Tadafumi ^a  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Bipolar disorder; Calcium; Lithium; Mitochondrial DNA; Valproate

Indexed keywords

ADENINE; CALCIUM; GUANINE; HISTAMINE; LITHIUM; MITOCHONDRIAL DNA; VALPROIC ACID;

ADULT; ALZHEIMER DISEASE; ARTICLE; BIPOLAR DISORDER; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CELL LINE; CELL PH; CONTROLLED STUDY; CYBRID; CYTOSOL; DNA POLYMORPHISM; FEMALE; FLUORESCENCE; HUMAN; HUMAN CELL; LONGEVITY; LYMPHOCYTE; MALE; NEOPLASM; PARKINSON DISEASE; PRIORITY JOURNAL; THROMBOCYTE;

ADULT; ANTIMANIC AGENTS; CALCIUM; CALCIUM SIGNALING; CELL LINE; CELL NUCLEUS; DNA, MITOCHONDRIAL; FEMALE; HISTAMINE; HUMANS; HYBRID CELLS; LITHIUM CHLORIDE; MALE; MITOCHONDRIA; VALPROIC ACID;

EID: 38149111856     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145707007614     Document Type: Article

References (52)

1. Berridge MJ (1985). Phosphoinositides and signal transductions. Reviews in Clinical and Basic Pharmacology 5 (Suppl.), 5S-13S.
2. Berridge MJ (1993). Inositol trisphosphate and calcium signalling. Nature 361, 315-325.
3. Berridge MJ, Downes CP, Hanley MR (1989). Neural and developmental actions of lithium : a unifying hypothesis. Cell 59, 411-419.
4. Berridge MJ, Lipp P, Bootman MD (2000). The versatility and universality of calcium signalling. Nature Reviews Molecular Cell Biology 1, 11-21.
5. 2+ mobilization from the intracellular stores of single histamine-stimulated HeLa cells. Journal of Physiology 450, 163-178.
6. Chen B, Wang JF, Young LT (2000). Chronic valproate treatment increases expression of endoplasmic reticulum stress proteins in the rat cerebral cortex and hippocampus. Biological Psychiatry 48, 658-664.
7. Chen G, Huang LD, Jiang YM, Manji HK (1999a). The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. Journal of Neurochemistry 72, 1327-1330.
8. Chen G, Zeng WZ, Yuan PX, Huang LD, Jiang YM, Zhao ZH, Manji HK (1999b). The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. Journal of Neurochemistry 72, 879-882.
9. Dubovsky SL, Christiano J, Daniell LC, Franks RD, Murphy J, Adler L, Baker N, Harris RA (1989). Increased platelet intracellular calcium concentration in patients with bipolar affective disorders. Archives of General Psychiatry 46, 632-638.
10. Dubovsky SL, Lee C, Christiano J, Murphy J (1991). Elevated platelet intracellular calcium concentration in bipolar depression. Biological Psychiatry 29, 441-450.
11. Dubovsky SL, Murphy J, Thomas M, Rademacher J (1992). Abnormal intracellular calcium ion concentration in platelets and lymphocytes of bipolar patients. American Journal of Psychiatry 149, 118-120.
12. Gershon ES, Badner JA, Detera-Wadleigh SD, Ferraro TN, Berrettini WH (1996). Maternal inheritance and chromosome 18 allele sharing in unilineal bipolar illness pedigrees. American Journal of Medical Genetics 67, 202-207.
13. 2+. Journal of Biological Chemistry 274, 14157-14162.
14. Hallcher LM, Sherman WR (1980). The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. Journal of Biological Chemistry 255, 10896-10901.
15. Harwood AJ, Agam G (2003). Search for a common mechanism of mood stabilizers. Biochemical Pharmacology 66, 179-189.
16. Hiroi T, Wei H, Hough C, Leeds P, Chuang DM (2005). Protracted lithium treatment protects against the ER stress elicited by thapsigargin in rat PC12 cells : roles of intracellular calcium, GRP78 and Bcl-2. Pharmacogenomics Journal 5, 102-111.
17. Hough C, Lu SJ, Davis CL, Chuang DM, Post RM (1999). Elevated basal and thapsigargin-stimulated intracellular calcium of platelets and lymphocytes from bipolar affective disorder patients measured by a fluorometric microassay. Biological Psychiatry 46, 247-255.
18. Kato T (2001). The other, forgotten genome: mitochondrial DNA and mental disorders. Molecular Psychiatry 6, 625-633.
19. Kato T, Inubushi T, Kato N (1998). Magnetic resonance spectroscopy in affective disorders. Journal of Neuropsychiatry and Clinical Neuroscience 10, 133-147.
20. Kato T, Kunugi H, Nanko S, Kato N (2001). Mitochondrial DNA polymorphisms in bipolar disorder. Journal of Affective Disorders 62, 151-164.
21. Kazuno AA, Munakata K, Nagai T, Shimozono S, Tanaka M, Yoneda M, Kato N, Miyawaki A, Kato T (2006). Identification of mitochondrial DNA polymorphisms that alter mitochondrial matrix pH and intracellular calcium dynamics. PLoS Genetics 2, e128.
22. King MP, Attardi G (1989). Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 246, 500-503.
23. Kirk R, Furlong RA, Amos W, Cooper G, Rubinsztein JS, Walsh C, Paykel ES, Rubinsztein DC (1999). Mitochondrial genetic analyses suggest selection against maternal lineages in bipolar affective disorder. American Journal of Human Genetics 65, 508-518.
24. Klein PS, Melton DA (1996). A molecular mechanism for the effect of lithium on development. Proceedings of the National Academy of Sciences USA 93, 8455-8459.
25. Kusumi I, Koyama T, Yamashita I (1991). Serotonin-stimulated Ca2+ response is increased in the blood platelets of depressed patients. Biological Psychiatry 30, 310-312.
26. Kusumi I, Koyama T, Yamashita I (1992). Thrombin-induced platelet calcium mobilization is enhanced in bipolar disorders. Biological Psychiatry 32, 731-734.
27. Kusumi I, Koyama T, Yamashita I (1994). Serotonin-induced platelet intracellular calcium mobilization in depressed patients. Psychopharmacology (Berlin) 113, 322-327.
28. Lai JS, Zhao C, Warsh JJ, Li PP (2006). Cytoprotection by lithium and valproate varies between cell types and cellular stresses. European Journal of Pharmacology 539, 18-26.
29. 2+. Journal of Biological Chemistry 272, 30873-30879.
30. McMahon FJ, Chen YS, Patel S, Kokoszka J, Brown MD, Torroni A, DePaulo JR, Wallace DC (2000). Mitochondrial DNA sequence diversity in bipolar affective disorder. American Journal of Psychiatry 157, 1058-1064.
31. McMahon FJ, Stine OC, Meyers DA, Simpson SG, DePaulo JR (1995). Patterns of maternal transmission in bipolar affective disorder. American Journal of Human Genetics 56, 1277-1286.
32. 2+. Proceedings of the National Academy of Sciences USA 98, 3197-3202.
33. Niemi AK, Moilanen JS, Tanaka M, Hervonen A, Hurme M, Lehtimaki T, Arai Y, Hirose N, Majamaa K (2005). A combination of three common inherited mitochondrial DNA polymorphisms promotes longevity in Finnish and Japanese subjects. European Journal of Human Genetics 13, 166-170.
34. Nigam SK, Goldberg AL, Ho S, Rohde MF, Bush KT, Sherman M (1994). A set of endoplasmic reticulum proteins possessing properties of molecular chaperones includes Ca(2+)-binding proteins and members of the thioredoxin superfamily. Journal of Biological Chemistry 269, 1744-1749.
35. O'Donnell T, Rotzinger S, Nakashima TT, Hanstock CC, Ulrich M, Silverstone PH (2000). Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain. Brain Research 880, 84-91.
36. Pacheco MA, Jope RS (1999). Modulation of carbachol-stimulated AP-1 DNA binding activity by therapeutic agents for bipolar disorder in human neuroblastoma SH-SY5Y cells. Brain Research. Molecular Brain Research 72, 138-146.
37. 2+ homeostasis in the endoplasmic reticulum. Cell Death & Differentiation 13, 1409-1418.
38. Shaltiel G, Shamir A, Shapiro J, Ding D, Dalton E, Bialer M, Harwood AJ, Belmaker RH, Greenberg ML, Agam G (2004). Valproate decreases inositol biosynthesis. Biological Psychiatry 56, 868-874.
39. Shao L, Sun X, Xu L, Young LT, Wang JF (2006). Mood stabilizing drug lithium increases expression of endoplasmic reticulum stress proteins in primary cultured rat cerebral cortical cells. Life Sciences 78, 1317-1323.
40. Shao L, Young LT, Wang JF (2005). Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells. Biological Psychiatry 58, 879-884.
41. Suomalainen A, Majander A, Haltia M, Somer H, Lonnqvist J, Savontaus ML, Peltonen L (1992). Multiple deletions of mitochondrial DNA in several tissues of a patient with severe retarded depression and familial progressive external ophthalmoplegia. Journal of Clinical Investigation 90, 61-66.
42. Suzuki K, Kusumi I, Sasaki Y, Koyama T (2001). Serotonin-induced platelet intracellular calcium mobilization in various psychiatric disorders : is it specific to bipolar disorder? Journal of Affective Disorders 64, 291-296.
43. van der Walt JM, Dementieva YA, Martin ER, Scott WK, Nicodemus KK, Kroner CC, Welsh-Bohmer KA, Saunders AM, Roses AD, Small GW, et al. (2004). Analysis of European mitochondrial haplogroups with Alzheimer disease risk. Neuroscience Letters 365, 28-32.
44. van der Walt JM, Nicodemus KK, Martin ER, Scott WK, Nance MA, Watts RL, Hubble JP, Haines JL, Koller WC, Lyons K, et al. (2003). Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. American Journal of Human Genetics 72, 804-811.
45. Varney MA, Godfrey PP, Drummond AH, Watson SP (1992). Chronic lithium treatment inhibits basal and agonist-stimulated responses in rat cerebral cortex and GH3 pituitary cells. Molecular Pharmacology 42, 671-678.
46. Wang JF, Bown C, Young LT (1999). Differential display PCR reveals novel targets for the mood-stabilizing drug valproate including the molecular chaperone GRP78. Molrcular Pharmacology 55, 521-527.
47. Washizuka S, Ikeda A, Kato N, Kato T (2003). Possible relationship between mitochondrial DNA polymorphisms and lithium response in bipolar disorder. International Journal of Neuropsychopharmacology 6, 421-424.
48. Wasserman MJ, Corson TW, Sibony D, Cooke RG, Parikh SV, Pennefather PS, Li PP, Warsh JJ (2004). Chronic lithium treatment attenuates intracellular calcium mobilization. Neuropsychopharmacology 29, 759-769.
49. Yamawaki S, Kagaya A, Okamoto Y, Shimizu M, Nishida A, Uchitomi Y (1996). Enhanced calcium response to serotonin in platelets from patients with affective disorders. Journal of Psychiatry and Neuroscience 21, 321-324.
50. Yuan PX, Huang LD, Jiang YM, Gutkind JS, Manji HK, Chen G (2001). The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. Journal of Biological Chemistry 276, 31674-31683.
51. Zhou R, Gray NA, Yuan P, Li X, Chen J, Chen G, Damschroder-Williams P, Du J, Zhang L, Manji HK (2005). The anti-apoptotic, glucocorticoid receptor cochaperone protein BAG-1 is a long-term target for the actions of mood stabilizers. Journal of Neuroscience 25, 4493-4502.
52. Zhu L, Ling S, Yu XD, Venkatesh LK, Subramanian T, Chinnadurai G, Kuo TH (1999). Modulation of mitochondrial Ca(2+) homeostasis by Bcl-2. Journal of Biological Chemistry 274, 33267-33273.